Mary Caffrey


Final Consensus Report on Type 1 Diabetes Released by ADA, EASD

October 04, 2021

Throughout, the guidance from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) calls for respecting the patient’s choices, including the fact that not all patients prefer insulin pumps or can afford them.

SGLT2 Inhibitors, GLP-1 RAs Featured in Prevention Guidelines

October 04, 2021

The prevention document, released during ESC Congress 2021, marked the first update of this section of the guidelines in 8 years. It featured changes that reflect the arrival of a pair of drug classes with proven benefits in CV outcomes but that experts say are underutilized.

Discoveries on Temperature and Touch Win Nobel in Medicine

October 04, 2021

David Julius, PhD, and Ardem Patapoutian, PhD, revealed the cellular mechanics of how sensations of touch translate into heat, cold, or pain. Their work has implications in everything from pain management to regulation of blood pressure to bladder control.

In Oncology Clinical Pathways, the Variability Isn’t With the Drugs

September 25, 2021

Experts who took part in Patient-Centered Oncology Care® 2021 said when guidelines recommend high-cost targeted therapies or immunotherapies, the focus must turn to areas such as imaging, diagnostic tests, and other elements that contribute to the cost of care.